Case number 1:21-cv-00662
Amgen Inc. et al v. MSN Laboratories Private Limited, et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 12, 2024 | 188 | STIPULATION TO EXTEND TIME for the Parties to Return or Destroy Confidential Material Subject to 42 of the Protective Order (D.I. 33) to March 13, 2024 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) (Entered: 02/12/2024) (2) |
| Nov 14, 2023 | 185 | [SEALED] STIPULATION of Dismissal as to USV by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) (Entered: 11/14/2023) (0) |
| Nov 14, 2023 | 186 | [SEALED] SO ORDERED re 185 Stipulation and Order ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 11/14/2023.This order has been emailed to local counsel. (dlw) (Entered: 11/14/2023) (0) |
| Nov 14, 2023 | 187 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 11/14/2023) (1) |
| Nov 8, 2023 | 181 | MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices for Trial - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Dorsney, Kenneth) (Main Document 181 replaced on 11/8/2023) (dlw). Modified on 11/8/2023 (dlw). (Entered: 11/08/2023) (4) |
| Nov 8, 2023 | 182 | ORDER GRANTING 181 MOTION for Exemption of Persons from the District Of Delaware's May 15, 2023 Standing Order on Personal Devices for Trial. Signed by Judge Maryellen Noreika on 11/8/2023. (dlw) (Entered: 11/08/2023) (4) |
| Nov 8, 2023 | 183 | [SEALED] STIPULATION of Dismissal as to Amgen and MSN by Amgen Inc., KAI Pharmaceuticals, Inc. (Jacobs, Karen) Modified on 11/8/2023 (dlw). (Entered: 11/08/2023) (0) |
| Nov 8, 2023 | 184 | [SEALED] SO ORDERED re 183 Stipulation of Dismissal (as to MSN defendants). Party MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. terminated. Attorney Kenneth Laurence Dorsney; Bradford C. Frese; Cortlan S. Hitch; Richard J. Berman and Janine A. Carlan terminated. Signed by Judge Maryellen Noreika on 11/8/2023. This order has been emailed to local counsel for Plaintiff and MSN. (dlw) (Entered: 11/08/2023) (0) |
| Nov 7, 2023 | 180 | ORDER AFTER PRETRIAL CONFERENCE. Signed by Judge Maryellen Noreika on 11/7/2023. (dlw) (Entered: 11/07/2023) (2) |
| Nov 6, 2023 | 177 | [SEALED] STIPULATION of Partial Dismissal as to MSN by Amgen Inc., KAI Pharmaceuticals, Inc. (Jacobs, Karen) Modified on 11/6/2023 (dlw). (Entered: 11/06/2023) (0) |
| Nov 6, 2023 | 178 | REDACTED VERSION of 174 Proposed Pretrial Order, by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 11/06/2023) (30) |
| Nov 6, 2023 | 179 | Official Transcript of Pretrial Conference held on 11/6/23 before Judge Maryellen Noreika. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/27/2023. Redacted Transcript Deadline set for 12/7/2023. Release of Transcript Restriction set for 2/5/2024. (Warner, Deanna) (Entered: 11/06/2023) (24) |
| Oct 31, 2023 | 175 | STIPULATION regarding Authenticity of Trial Exhibits -- by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 10/31/2023) (2) |
| Oct 31, 2023 | 176 | SO ORDERED re 175 Stipulation and Order (regarding authenticity of trial exhibits). Signed by Judge Maryellen Noreika on 10/31/2023. (dlw) (Entered: 10/31/2023) (2) |
| Oct 30, 2023 | 174 | [SEALED] Proposed Pretrial Order by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 5, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Clark, Cameron) (Entered: 10/30/2023) (0) |
| Oct 25, 2023 | 171 | STIPULATION Amending Case Caption by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) (Entered: 10/25/2023) (3) |
| Oct 25, 2023 | 172 | SO ORDERED re 171 Stipulation Amending Case Caption. Signed by Judge Maryellen Noreika on 10/25/2023. (dlw) (Entered: 10/25/2023) (3) |
| Oct 25, 2023 | 173 | REDACTED VERSION of 168 Stipulation of Dismissal by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 10/25/2023) (4) |
| Oct 24, 2023 | 170 | MOTION for Pro Hac Vice Appearance of Attorney Richard A. Lowry and Andrew Kerrick - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 10/24/2023) (6) |
| Oct 19, 2023 | 169 | [SEALED] SO ORDERED re 168 Stipulation of Dismissal. Party Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, AuroMedics Pharma LLC terminated. Attorney Kenneth Laurence Dorsney and Cortlan S. Hitch terminated as to these defendants. Signed by Judge Maryellen Noreika on 10/19/2023. This order has been emailed to local counsel. (dlw) (Entered: 10/19/2023) (0) |
| Oct 18, 2023 | 168 | [SEALED] STIPULATION of Dismissal by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) (Main Document 168 replaced on 10/19/2023) (dlw). (Entered: 10/18/2023) (0) |
| Oct 6, 2023 | 167 | NOTICE of Appearance by Veronica McCarty on behalf of USV Private Limited (McCarty, Veronica) (Entered: 10/06/2023) (2) |
| Sep 8, 2023 | 166 | NOTICE OF SERVICE of Defendants Aurobindo, MSN and USV's Joint Reply Expert Report of Keith Klein filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 09/08/2023) (3) |
| Sep 1, 2023 | 165 | NOTICE OF SERVICE of Defendant MSN's Reply Expert Report of Dr. John P. Mayer filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 09/01/2023) (3) |
| Aug 28, 2023 | 164 | NOTICE OF SERVICE of Defendants Aurobindo, MSN and USV's Joint Reply Expert Report of Laird M. Forrest, Ph.D. filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 08/28/2023) (3) |
| Aug 22, 2023 | 163 | STIPULATION TO EXTEND TIME of Expert Deadlines to Various Dates (See Stipulation) - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 08/22/2023) (2) |
| Jul 28, 2023 | 161 | NOTICE OF SERVICE of Expert Report of Jane V. Aldrich, Ph.D. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 07/28/2023) (4) |
| Jul 28, 2023 | 162 | NOTICE OF SERVICE of (1) Expert Report of Dr. Elizabeth Topp, Ph.D. and (2) Expert Report of Kevin Martin, M.D. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 07/28/2023) (6) |
| Jul 12, 2023 | 160 | STIPULATION TO EXTEND TIME to Serve Rebuttal Expert Reports by one week to July 28, 2023 and Time to Serve Reply Expert Reports by One Week to August 25, 2023 to - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) (Entered: 07/12/2023) (2) |
| Jun 1, 2023 | 158 | NOTICE OF SERVICE of MSN's Opening Expert Report of Dr. Mayer filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 06/01/2023) (3) |
| Jun 1, 2023 | 159 | NOTICE OF SERVICE of Aurobindo, MSN and USV's Opening Expert Report of Dr. Forrest filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., USV Private Limited.(Dorsney, Kenneth) (Entered: 06/01/2023) (3) |
| May 9, 2023 | 157 | STIPULATION TO EXTEND TIME expert discovery deadlines to (various - see stipulation) - filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 05/09/2023) (3) |
| Feb 10, 2023 | 154 | STIPULATION of Voluntary Dismissal without Prejudice and Proposed Consolidation Order by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 02/10/2023) (3) |
| Feb 10, 2023 | 155 | ANSWER to Complaint regarding U.S. Patent No. 11,162,500 in response to Complaint in C.A. No. 23-31 by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Hitch, Cortlan) Modified on 2/10/2023 (dlw). (Entered: 02/10/2023) (18) |
| Feb 10, 2023 | 156 | SO ORDERED re (11 in 1:23-cv-00031-MN, 154 in 1:21-cv-00662-MN) Stipulation of Voluntary Dismissal without Prejudice and Proposed Consolidation Order. Party MSN Life Sciences Private Limited terminated. Attorney Kenneth Laurence Dorsney terminated as to this Defendant. Signed by Judge Maryellen Noreika on 2/10/2023. (dlw) (Entered: 02/10/2023) (3) |
| Jan 13, 2023 | 153 | NOTICE requesting Clerk to remove Brian H. Gold as co-counsel.. (Dorsney, Kenneth) (Entered: 01/13/2023) (1) |
| Jan 4, 2023 | 151 | Letter to The Honorable Maryellen Noreika from Karen Jacobs regarding Markman hearing. (Jacobs, Karen) (Entered: 01/04/2023) (1) |
| Jan 4, 2023 | 152 | ORAL ORDER re 151 Letter - The parties having advised the Court "that they have no claim construction disputes to raise with the Court", IT IS HEREBY ORDERED that the 4/19/2023 Claim Construction hearing is taken all calendar. Scheduling Order deadline TERMINATED. ORDERED by Judge Maryellen Noreika on 1/4/2023. (dlw) (Entered: 01/04/2023) (0) |
| Dec 23, 2022 | 148 | NOTICE OF SERVICE of Second Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-12) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Dorsney, Kenneth) Modified on 1/3/2023 (dlw). (Entered: 12/23/2022) (3) |
| Dec 23, 2022 | 149 | NOTICE OF SERVICE of (1) Plaintiffs' Final Validity Contentions for U.S. Patent Nos. 8,999,932, 8,377,880, 9,278,995, and 9,701,712; (2) Plaintiffs' Final Validity Contentions for U.S. Patent Nos. 9,820,938, 10,344,765, and 11,165,500 filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Jacobs, Karen) (Entered: 12/23/2022) (5) |
| Dec 23, 2022 | 150 | NOTICE OF SERVICE of Aurobindo Pharma Limited's and Aurobindo Pharma USA, Inc.'s Second Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-12) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Dorsney, Kenneth) Modified on 1/3/2023 (dlw). (Entered: 12/23/2022) (3) |
| Dec 20, 2022 | 147 | REDACTED VERSION of 144 Stipulation by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 12/20/2022 (dlw). (Entered: 12/20/2022) (3) |
| Dec 15, 2022 | 145 | [SEALED] SO ORDERED re 144 Stipulation and Order regarding infringement (as to Defendant USV Private Limited). Signed by Judge Maryellen Noreika on 12/15/2022. This order has been emailed to local counsel. (dlw) (Entered: 12/15/2022) (0) |
| Dec 15, 2022 | 146 | STIPULATION TO EXTEND TIME of certain case deadlines to December 23, 2022 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 12/15/2022) (2) |
| Dec 14, 2022 | 144 | [SEALED] STIPULATION and Order Regarding Infringement (as to Defendant USV Private Limited) by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 12/15/2022 (dlw). (Entered: 12/14/2022) (0) |
| Dec 8, 2022 | 141 | NOTICE to Take Deposition of Rohit Ghan on December 13, 2022 (Amended) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 12/08/2022) (3) |
| Dec 8, 2022 | 142 | NOTICE to Take Deposition of Rahul Gupta on December 12, 2022 (Amended) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 12/08/2022) (3) |
| Dec 8, 2022 | 143 | NOTICE to Take Deposition of Chetan Doshi on December 15, 2022 (Amended) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 12/08/2022) (3) |
| Dec 1, 2022 | 139 | REDACTED VERSION of 135 Stipulation by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 12/1/2022 (dlw). (Entered: 12/01/2022) (4) |
| Dec 1, 2022 | 140 | REDACTED VERSION of 136 Stipulation by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 12/1/2022 (dlw). (Entered: 12/01/2022) (3) |
| Nov 29, 2022 | 135 | [SEALED] STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.) by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 11/29/2022 (dlw). (Entered: 11/29/2022) (0) |
| Nov 29, 2022 | 136 | [SEALED] STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and Auromedics Pharma LLC) by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 11/29/2022 (dlw). (Entered: 11/29/2022) (0) |
| Nov 29, 2022 | 137 | [SEALED] SO ORDERED re 135 Stipulation and Order Regarding Infringement (as to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.). Signed by Judge Maryellen Noreika on 11/29/2022. This order has been emailed to local counsel. (dlw) (Entered: 11/29/2022) (0) |
| Nov 29, 2022 | 138 | [SEALED] SO ORDERED re 136 Stipulation and Order Regarding Infringement (as to Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and Auromedics Pharma LLC). Signed by Judge Maryellen Noreika on 11/29/2022. This order has been emailed to local counsel. (dlw) (Entered: 11/29/2022) (0) |
| Nov 23, 2022 | 133 | NOTICE to Take Deposition of Rohit Ghan on December 1, 2022 filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 11/23/2022) (3) |
| Nov 23, 2022 | 134 | NOTICE to Take Deposition of Ravikumar Nithiyanandam on December 5-6, 2022 filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 11/23/2022) (3) |
| Nov 17, 2022 | 131 | STIPULATION TO EXTEND TIME of certain case deadlines to various dates - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 11/17/2022) (2) |
| Nov 17, 2022 | 132 | SO ORDERED re 131 STIPULATION TO EXTEND certain case deadlines to various dates (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 12/16/2022). SEE STIPULATION FOR FURTHER DATES. Signed by Judge Maryellen Noreika on 11/17/2022. (dlw) (Entered: 11/17/2022) (2) |
| Nov 4, 2022 | 130 | NOTICE OF SERVICE of Defendant USV Private Limited's Objections and Responses to Plaintiffs' First Set of Requests for Admission to Defendant USV Private Limited filed by USV Private Limited.(Glazer, Joel) (Entered: 11/04/2022) (2) |
| Oct 27, 2022 | 129 | NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to MSN's First Set of Interrogatories (Nos. 1-6) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Blumenfeld, Jack) (Entered: 10/27/2022) (5) |
| Oct 26, 2022 | 128 | NOTICE OF SERVICE of MSN's First Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-12) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 10/26/2022) (3) |
| Oct 21, 2022 | 124 | NOTICE OF SERVICE of (1) Defendants Aurobindo, MSN and USV's Joint Invalidity Contentions of the Formulation Patents and; (2) MSN's Supplemental Invalidity Contentions filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 10/21/2022) (3) |
| Oct 21, 2022 | 125 | NOTICE OF SERVICE of Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Final Infringement Contentions for Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, and Auromedics Pharma LLC filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 10/21/2022) (5) |
| Oct 21, 2022 | 126 | NOTICE OF SERVICE of Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Final Infringement Contentions for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 10/21/2022) (3) |
| Oct 21, 2022 | 127 | NOTICE OF SERVICE of Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Final Infringement Contentions for Defendant USV Private Limited filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 10/21/2022) (3) |
| Oct 19, 2022 | 123 | NOTICE OF SERVICE of Defendant USV Private Limited's Objections and Responses to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Defendant USV Private Limited filed by USV Private Limited.(Lennon, James) (Entered: 10/19/2022) (2) |
| Oct 14, 2022 | 122 | MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson - filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 10/14/2022) (3) |
| Oct 13, 2022 | 121 | NOTICE OF SERVICE of Plaintiffs Amgen Inc. and KAI Pharmaceuticals, Inc.'s Responses and Objections to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 10/13/2022) (5) |
| Oct 7, 2022 | 120 | NOTICE OF SERVICE of (1) Aurobindo's Objections to Plaintiffs' 30(b)(6) Deposition Notice; and (2) MSN's Objections to Plaintiffs' 30(b)(6) Deposition Notice filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 10/07/2022) (3) |
| Sep 29, 2022 | 119 | NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' First Set of Requests for Admission (Nos. 1-17); and (2) MSN's response to Plaintiff's First Set of Requests for Admission (Nos. 1-21) filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 09/29/2022) (3) |
| Sep 27, 2022 | 117 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendant USV Private Limited - filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Blumenfeld, Jack) (Entered: 09/27/2022) (3) |
| Sep 27, 2022 | 118 | NOTICE OF SERVICE of (1) Amos Baruch's Responses and Objections to MSN's Notice of Subpoena and (2) Felix Karim's Responses and Objections to MSN's Notice of Subpoena - filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Blumenfeld, Jack) (Entered: 09/27/2022) (3) |
| Sep 22, 2022 | 116 | SO ORDERED re 115 Stipulation and Order to Extend Scheduling Order deadlines (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 12/14/2022). SEE STIPULATION FOR FURTHER DETAILS. Signed by Judge Maryellen Noreika on 9/22/2022. (dlw) (Entered: 09/22/2022) (2) |
| Sep 21, 2022 | 115 | STIPULATION to extend certain discovery deadlines by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 09/21/2022) (3) |
| Sep 19, 2022 | 112 | REDACTED VERSION of 109 Notice (Other) by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 09/19/2022) (30) |
| Sep 19, 2022 | 113 | REDACTED VERSION of 110 Notice (Other) by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 09/19/2022) (30) |
| Sep 19, 2022 | 114 | MOTION for Pro Hac Vice Appearance of Attorney Janine A. Carlan - filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited. (Dorsney, Kenneth) (Main Document 114 replaced on 9/19/2022) (dlw). (Entered: 09/19/2022) (3) |
| Sep 16, 2022 | 111 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.: Entry of appearance of attorney Kenneth Laurence Dorsney. Attorney Neal C. Belgam and Eve H. Ormerod terminated. (Dorsney, Kenneth) (Entered: 09/16/2022) (2) |
| Sep 15, 2022 | 109 | [SEALED] NOTICE of Subpoena to Produce Documents and Testimony to Amos Baruch by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) (Entered: 09/15/2022) (0) |
| Sep 15, 2022 | 110 | [SEALED] NOTICE of Subpoena to Produce Documents and Testimony to Felix Karim by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) (Entered: 09/15/2022) (0) |
| Sep 13, 2022 | 107 | NOTICE requesting Clerk to remove Steven J. Moore, James E. Nealon and Lina Genovesi as co-counsel.. (Dorsney, Kenneth) (Entered: 09/13/2022) (2) |
| Sep 13, 2022 | 108 | MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Attorney Bradford C. Frese, Attorney Brian H. Gold and Attorney Sailesh K. Patel - filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited. (Dorsney, Kenneth) (Entered: 09/13/2022) (6) |
| Sep 12, 2022 | 106 | NOTICE OF SERVICE of Defendants' Notice of Deposition to Plaintiffs Amgen Inc., and Kai Pharmaceuticals, Inc., Pursuant to Fed. R. Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 09/12/2022) (15) |
| Sep 9, 2022 | 103 | NOTICE to Take Deposition of Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Eugia Pharma Specialties Limited, and AuroMedics Pharma LLC on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/09/2022) (10) |
| Sep 9, 2022 | 104 | NOTICE to Take Deposition of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/09/2022) (11) |
| Sep 9, 2022 | 105 | NOTICE to Take Deposition of Defendant USV Private Limited on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/09/2022) (10) |
| Sep 2, 2022 | 97 | NOTICE to Take Deposition of Adarsh Jain on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 98 | NOTICE to Take Deposition of V. Naga Prasad on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 99 | NOTICE to Take Deposition of Kondal Reddy Bairy on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 100 | NOTICE to Take Deposition of Ravi Kumar Nithiyanandam on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 101 | NOTICE to Take Deposition of Chetan Doshi on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 102 | NOTICE to Take Deposition of Rahul Gupta on a date and time mutually agreed upon by the parties filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 09/02/2022) (3) |
| Aug 30, 2022 | 95 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendants MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., and MSN Life Sciences Private Limited filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 08/30/2022) (3) |
| Aug 30, 2022 | 96 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Eugia Pharma Specialties Limited, and Auromedics Pharma LLC filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) (Entered: 08/30/2022) (3) |
| Aug 25, 2022 | 93 | NOTICE to Take Deposition of Derek Maclean on September 19, 2022 filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited.(Dorsney, Kenneth) (Entered: 08/25/2022) (4) |
| Aug 25, 2022 | 94 | NOTICE to Take Deposition of Qun Yin on September 22, 2022 filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited.(Dorsney, Kenneth) (Entered: 08/25/2022) (4) |
| Aug 16, 2022 | 92 | NOTICE OF SERVICE of Initial Invalidity Contentions by USV Private Limited (Lennon, James) Modified on 8/16/2022 (dlw). (Entered: 08/16/2022) (2) |
| Aug 11, 2022 | 91 | STIPULATION TO EXTEND TIME for MSN to substantially complete its production of documents to August 18, 2022 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Belgam, Neal) (Entered: 08/11/2022) (2) |
| Aug 1, 2022 | 90 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant USV Private Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-12); and (2) Defendant USV Private Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to Defendant USV Private Limited filed by USV Private Limited.(Lennon, James) |
| Jul 27, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Jul 13, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese, and Brian H. Gold for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jul 13, 2022 | 88 | Stipulation (2) Docket Text: STIPULATION for Discovery, Including Discovery of Electronically Stored Information ("ESI") by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) |
| Jul 13, 2022 | 89 | SO ORDERED (2) Docket Text: SO ORDERED re [88] Stipulation for Discovery, Including Discovery of Electronically Stored Information ("ESI") (between Plaintiffs and USV Private Limited). Signed by Judge Maryellen Noreika on 7/13/2022. (dlw) |
| Jul 12, 2022 | 87 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Amgen Inc. and KAI Pharmaceuticals, Inc.'s Initial Infringement Contentions for Defendant USV Private Limited filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) |
| Jul 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [86] MOTION for Pro Hac Vice Appearance of Attorney Brian Gold, Bradford Frese, Janine Carlan, and Richard Berman filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 7/7/2022. (dlw) |
| Jul 7, 2022 | 85 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Alan H. Pollack, H. Howard Wang, and Amlan Ray as co-counsel. Reason for request: no longer associated with this matter. (Ormerod, Eve) |
| Jul 7, 2022 | 86 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brian Gold, Bradford Frese, Janine Carlan, and Richard Berman - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Counsel - Brian Gold, # (2) Certification of Counsel - Bradford Frese, # (3) Certification of Counsel - Janine Carlan, # (4) Certification of Counsel - Richard Berman)(Ormerod, Eve) |
| Jul 7, 2022 | 86 | Certification of Counsel - Brian Gold (1) |
| Jul 7, 2022 | 86 | Certification of Counsel - Bradford Frese (1) |
| Jul 7, 2022 | 86 | Certification of Counsel - Janine Carlan (1) |
| Jul 7, 2022 | 86 | Certification of Counsel - Richard Berman (1) |
| Jun 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [84] STIPULATION TO EXTEND TIME for substantial completion of production for MSN, Aurobindo, and Amgen to August 11, 2022. ORDERED by Judge Maryellen Noreika on 6/17/2022. (dlw) |
| Jun 17, 2022 | 84 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for substantial completion of production for MSN, Aurobindo, and Amgen to August 11, 2022 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Jun 15, 2022 | 83 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production of Documents and Things to Defendant USV Private Limited and (2) Plaintiffs' First Set of Interrogatories to Defendant USV Private Limited filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) |
| Jun 14, 2022 | 81 | Proposed Order (2) Docket Text: PROPOSED ORDER // Addendum to Protective Order by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 6/14/2022 (dlw). |
| Jun 14, 2022 | 82 | Protective Order (2) Docket Text: ADDENDUM TO STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 6/14/2022. (dlw) |
| Jun 13, 2022 | 79 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures to USV Pursuant to Paragraph 3 of The Delaware Default Standard for Discovery; (2) Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Initial Disclosures to USV Pursuant to Fed. R. Civ. P. 26(a); and (3) Plaintiffs' Initial Disclosures to USV Identifying Accused Products and Asserted Patents filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Clark, Cameron) |
| Jun 13, 2022 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of USV Private Limiteds Rule 26(a)(1) Initial Disclosures and District of Delaware Default Standard for Discovery Paragraph 3 Disclosures filed by USV Private Limited.(Lennon, James) |
| Jun 6, 2022 | 78 | SO ORDERED (7) Docket Text: SO ORDERED re (16 in 1:22-cv-00387-MN, 77 in 1:21-cv-00662-MN) Stipulation and Order for Consolidation. Signed by Judge Maryellen Noreika on 6/6/2022. (dlw) |
| Jun 3, 2022 | 77 | Main Document (3) Docket Text: STIPULATION for Consolidation by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Clark, Cameron) |
| Jun 3, 2022 | 77 | Exhibit A (4) |
| May 16, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [76] MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. ORDERED by Judge Maryellen Noreika on 5/16/2022. (dlw) |
| May 16, 2022 | 76 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Apr 25, 2022 | 75 | Notice (Other) (1) Docket Text: NOTICE of of Withdrawal of Appearance of Caroline Sun by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) |
| Apr 19, 2022 | 74 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Aurobindo and MSN's Joint Initial Invalidity Contentions for the '500 Patent filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Apr 18, 2022 | 73 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants Initial Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Belgam, Neal) |
| Apr 7, 2022 | 71 | SO ORDERED (3) Docket Text: SO ORDERED re (70 in 1:21-cv-00662-MN, 14 in 1:22-cv-00227-MN) Stipulation and Order regarding consolidation. Signed by Judge Maryellen Noreika on 4/7/2022. (dlw) |
| Apr 7, 2022 | 72 | Answer to Complaint (13) Docket Text: ANSWER to Complaint, Counterclaims -- Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Answer to Defendant Aurobindo's Counterclaims (D.I. 11 in C.A. 22-227) by Amgen Inc., KAI Pharmaceuticals, Inc. (Blumenfeld, Jack) Modified on 4/8/2022 (dlw). |
| Apr 6, 2022 | 70 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Consolidate by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) |
| Apr 1, 2022 | 69 | Notice (Other) (4) Docket Text: NOTICE of Withdrawal of Counsel (Michelle Streifthau-Livizos) by Amgen Inc., KAI Pharmaceuticals, Inc. (Streifthau-Livizos, Michelle) |
| Mar 2, 2022 | 66 | Answer to Counterclaim (13) Docket Text: ANSWER to [59] Answer to Complaint, Counterclaim by Amgen Inc., KAI Pharmaceuticals, Inc. (Streifthau-Livizos, Michelle) Modified on 3/2/2022 (dlw). |
| Mar 2, 2022 | 67 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions Regarding U.S. Patent No. 11,162,500 for Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. Eugia Pharma Specialties Limited, and AuroMedics Pharma LLC filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Mar 2, 2022 | 68 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions Regarding U.S. Patent No. 11,162,500 for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Feb 25, 2022 | 63 | Stipulation (7) Docket Text: STIPULATION and [Proposed] Order for Discovery, Including Discovery of Electronically Stored Information ("ESI") - by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Feb 25, 2022 | 64 | SO ORDERED (7) Docket Text: SO ORDERED re [63] Stipulation for Discovery, Including Discovery of Electronically Stored Information ("ESI"). Signed by Judge Maryellen Noreika on 2/25/2022. (dlw) |
| Feb 25, 2022 | 65 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to MSN's First Set of Interrogatories (Nos. 1-6) and (2) Plaintiffs' Objections and Responses to MSN's First Set of Requests for Production of Documents and Things (Nos. 1-101) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Feb 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [62] MOTION for Pro Hac Vice Appearance of Attorney Olivia Martzahn and David Y. Wang filed by Amgen Inc., KAI Pharmaceuticals, Inc.. ORDERED by Judge Maryellen Noreika on 2/18/2022. (mdb) |
| Feb 18, 2022 | 62 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Olivia Martzahn and David Y. Wang - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Feb 9, 2022 | 59 | Answer to Complaint (30) Docket Text: ANSWER to Complaint // Aurobindo, AuroMedics and Eugia's Answer, Affirmative Defenses, and Counterclaims to the Complaint filed in the 22-37 matter, COUNTERCLAIM against All Plaintiffs by Eugia Pharma Specialties Limited, Aurobindo Pharma Limited, AuroMedics Pharma LLC, Aurobindo Pharma USA Inc.(Dorsney, Kenneth) Modified on 2/9/2022 (dlw). |
| Feb 9, 2022 | 60 | Answer to Complaint (29) Docket Text: ANSWER to Complaint // MSN's Answer and Additional Defenses to the Complaint filed in the 22-37 matter by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) Modified on 2/10/2022 (dlw). |
| Feb 9, 2022 | 61 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Feb 3, 2022 | 58 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: These cases (C.A. No. 21-662 and C.A. No. 22-37) are consolidated for all purposes, including trial. Joinder of Parties due by 9/1/2022. Amended Pleadings due by 9/1/2022. Fact Discovery completed by 9/29/2022. Opening Expert Reports due by 5/11/2023. Rebuttal Expert Reports due by 6/29/2023. Reply Expert Reports due by 7/27/2023. Expert Discovery due by 9/14/2023. Claim Construction Opening Brief served by 1/19/2023. Claim Construction Answering Brief served by 2/9/2023. Claim Construction Reply Brief served by 2/23/2023. Claim Construction Surreply Brief served by 3/9/2023. Joint Claim Construction Brief filed by 3/16/2023. A Markman Hearing is set for 4/19/2023 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 11/6/2023 at 11:00 AM in Courtroom 4A before Judge Maryellen Noreika. A 5- day Bench Trial is set for 11/13/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 2/3/2022. (dlw) |
| Feb 1, 2022 | 57 | Proposed Order (15) Docket Text: PROPOSED ORDER -- [Proposed] Revised Scheduling Order -- by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Jan 28, 2022 | 56 | Answer to Counterclaim (12) Docket Text: ANSWER to [49] Answer to Amended Complaint, Counterclaim by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Jan 26, 2022 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Initial Invalidity Contentions filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Jan 26, 2022 | 55 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s 1) First Set of Requests for Production of Documents and Things (Nos. 1-101) and 2) First Set of Interrogatories (Nos. 1-6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Jan 25, 2022 | 53 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Preliminary Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Jan 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [52] STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. to serve Initial Invalidity Contentions to January 28, 2022. ORDERED by Judge Maryellen Noreika on 1/24/2022. (dlw) |
| Jan 21, 2022 | 52 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. to serve Initial Invalidity Contentions to January 28, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Jan 11, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Howard Wang and Amlan Ray for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Jan 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [51] MOTION for Pro Hac Vice Appearance of Attorney Amlan Ray, H. Howard Wang filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 1/10/2022. (dlw) |
| Jan 10, 2022 | 51 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amlan Ray, H. Howard Wang - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Jan 7, 2022 | 49 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [46] Amended Complaint, , COUNTERCLAIM against All Plaintiffs by AuroMedics Pharma LLC, Eugia Pharma Specialties Limited, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Jan 7, 2022 | 50 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for AuroMedics Pharma LLC, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited filed by AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited. (Dorsney, Kenneth) |
| Jan 6, 2022 | 48 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Amit Singhai by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) |
| Dec 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [47] Joint STIPULATION TO EXTEND TIME for Defendants MSN and Aurobindo to serve their Initial Invalidity Contentions from December 22, 2021, to January 21, 2022. ORDERED by Judge Maryellen Noreika on 12/21/2021. (dlw) |
| Dec 21, 2021 | 47 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants MSN and Aurobindo to serve their Initial Invalidity Contentions from December 22, 2021, to January 21, 2022 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Dec 20, 2021 | 45 | SO ORDERED (3) Docket Text: SO ORDERED re [44] Stipulation and Order Granting Leave to File First Amended Complaint Against Aurobindo. Signed by Judge Maryellen Noreika on 12/20/2021. (dlw) |
| Dec 20, 2021 | 46 | Main Document (18) Docket Text: FIRST AMENDED COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., AuroMedics Pharma LLC, Eugia Pharma Specialties Limited- filed by Amgen Inc., KAI Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A & B, # (2) Redline Comparison)(dlw) |
| Dec 20, 2021 | 46 | Exhibit A & B (60) |
| Dec 20, 2021 | 46 | Redline Comparison (20) |
| Dec 20, 2021 | 46 | Amended Complaint* (1) |
| Dec 17, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 44 has been deleted at the request of counsel. (dlw) |
| Dec 17, 2021 | 44 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order Granting Leave to File First Amended Complaint Against Aurobindo by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Streifthau-Livizos, Michelle) |
| Dec 17, 2021 | 44 | Exhibit A (79) |
| Dec 17, 2021 | 44 | Exhibit B (81) |
| Dec 6, 2021 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' First Set of Interrogatories (Nos. 1-12); and (2) Aurobindo's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-71) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Nov 29, 2021 | 42 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of 1) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-71) and 2) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-12) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Nov 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [41] MOTION for Pro Hac Vice Appearance of Attorney Alan H. Pollack filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 11/23/2021. (dlw) |
| Nov 23, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alan H. Pollack for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Nov 22, 2021 | 41 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alan H. Pollack - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Nov 19, 2021 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Amgen Inc. and KAI Pharmaceuticals, Inc.'s Initial Infringement Contentions for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Nov 19, 2021 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Amgen Inc. and KAI Pharmaceuticals, Inc.'s Initial Infringement Contentions for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Nov 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [38] MOTION for Pro Hac Vice Appearance of Attorney Alaina M. Whitt filed by Amgen Inc., KAI Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 11/16/2021. (dlw) |
| Nov 16, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alaina M. Whitt for Amgen Inc. and KAI Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Nov 16, 2021 | 38 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alaina M. Whitt - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Oct 22, 2021 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. and (2) Plaintiffs' First Set of Requests for Production of Documents and Things to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Jacobs, Karen) |
| Oct 22, 2021 | 37 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. and (2) Plaintiffs' First Set of Requests for Production of Documents and Things to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Jacobs, Karen) |
| Oct 21, 2021 | 35 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Core Technical Documents filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Oct 20, 2021 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Aurobindo's Core Technical Documents filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Oct 5, 2021 | 33 | Protective Order (27) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 10/5/2021. (dlw) |
| Oct 4, 2021 | 32 | Main Document (27) Docket Text: PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Letter to the Honorable The Honorable Maryellen Noreika)(Jacobs, Karen) |
| Oct 4, 2021 | 32 | Letter to the Honorable The Honorable Maryellen Noreika (1) |
| Sep 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [31] STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to October 4, 2021. ORDERED by Judge Maryellen Noreika on 9/27/2021. (dlw) |
| Sep 24, 2021 | 31 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to October 4, 2021 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Sep 21, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amit Singhai,Caroline Sun for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Sep 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [29] MOTION for Pro Hac Vice Appearance of Attorney Caroline Sun and Amit Singhai filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 9/20/2021. (dlw) |
| Sep 20, 2021 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Sep 20, 2021 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Default Standard For Discovery, Including Discovery of Electronically Stored Information filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Sep 20, 2021 | 29 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Caroline Sun and Amit Singhai - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Proposed Order)(Ormerod, Eve) |
| Sep 20, 2021 | 29 | Certification (1) |
| Sep 20, 2021 | 29 | Certification (1) |
| Sep 20, 2021 | 29 | Proposed Order (1) |
| Sep 20, 2021 | 30 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and (2) Plaintiffs' Initial Disclosures Identifying Accused Products and Asserted Patents filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Sep 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [26] STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 27, 2021. ORDERED by Judge Maryellen Noreika on 9/16/2021. (dlw) |
| Sep 16, 2021 | 26 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 27, 2021 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Sep 10, 2021 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.'s Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Sep 10, 2021 | 24 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs Amgen Inc. and Kai Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Amgen Inc., KAI Pharmaceuticals, Inc..(Streifthau-Livizos, Michelle) |
| Sep 10, 2021 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Pharmaceuticals Ltd.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Aug 30, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 8/30/2021. (dlb) |
| Aug 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Aug 27, 2021 | 21 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These cases are CONSOLIDATED for all purposes, including trial, and all future filings shall be made in the lead action. Joinder of Parties due by 11/3/2022. Amended Pleadings due by 11/3/2022. Fact Discovery completed by 12/1/2022. Opening Expert Reports due by 3/1/2023. Rebuttal Expert Reports due by 4/27/2023. Reply Expert Report due by 5/31/2023. Expert Discovery due by 7/26/2023. Claim Construction Opening Brief served by 3/16/2022. Claim Construction Answering Brief served by 5/4/2022. Claim Construction Reply Brief served by 6/3/2022. Claim Construction Surreply Brief served by 6/28/2022. Joint Claim Construction Brief filed by 7/22/2022. A Markman Hearing is set for 8/24/2022 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 11/6/2023 at 11:00 AM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 11/13/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 8/27/2021. (dlw) |
| Aug 24, 2021 | 20 | Main Document (14) Docket Text: PROPOSED ORDER // Scheduling Order by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Cover Letter to The Honorable Maryellen Noreika)(Streifthau-Livizos, Michelle) Modified on 8/25/2021 (dlw). |
| Aug 24, 2021 | 20 | Cover Letter to The Honorable Maryellen Noreika (1) |
| Aug 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:21-cv-00662-MN, 20 in 1:21-cv-00712-MN) STIPULATION TO EXTEND TIME to submit a proposed scheduling order to August 24, 2021. ORDERED by Judge Maryellen Noreika on 8/20/2021. (dlw) |
| Aug 19, 2021 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed scheduling order to August 24, 2021 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Jul 28, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Paula S. Fritsch, Joseph E. Lasher for Amgen Inc., KAI Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jul 20, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed, coordinated order, including a proposal for the length and timing of trial, to the Court no later than thirty (30) days from the date of this Order. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 7/20/2021. (dlw) |
| Jul 9, 2021 | 17 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove David J. Lehr as co-counsel. Reason for request: leaving the firm. (Jacobs, Karen) |
| Jul 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore,James E. Nealon for Aurobindo Pharma Limited, and for Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
| Jul 1, 2021 | 16 | Answer to Counterclaim (12) Docket Text: ANSWER to [14] Answer to Complaint, Counterclaim // Answer to Counterclaims by Amgen Inc., KAI Pharmaceuticals, Inc. (Jacobs, Karen) Modified on 7/1/2021 (dlw). |
| Jun 10, 2021 | 14 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Amgen Inc., KAI Pharmaceuticals, Inc. by Aurobindo Pharma USA Inc., Aurobindo Pharma Limited.(Dorsney, Kenneth) |
| Jun 10, 2021 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| May 27, 2021 | 13 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Michelle Streifthau-Livizos (Streifthau-Livizos, Michelle) |
| May 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [12] STIPULATION TO EXTEND TIME to answer, move or otherwise plead in response to the complaint to June 10, 2021 (Set/Reset Answer Deadlines: Aurobindo Pharma Limited answer due 6/10/2021; Aurobindo Pharma USA Inc. answer due 6/10/2021). ORDERED by Judge Maryellen Noreika on 5/25/2021. (dlw) |
| May 24, 2021 | 12 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME respond to complaint to June 10, 2021 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Dorsney, Kenneth) Modified on 5/25/2021 (dlw). |
| May 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [11] MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. ORDERED by Judge Maryellen Noreika on 5/21/2021. (dlw) |
| May 21, 2021 | 11 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| May 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [9] MOTION for Pro Hac Vice Appearance of Attorney Adam L. Perlman, Benjamin J. Behrendt, David J. Lehr, Arlene L. Chow, Michelle L. Ernst, Marc N. Zubick and Yi Sun, [10] MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford, Joseph E. Lasher and Paula S. Fritsch filed by Amgen Inc., KAI Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 5/13/2021. (dlw) |
| May 12, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| May 10, 2021 | 8 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Aurobindo Pharma Limited on May 10, 2021, filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| May 10, 2021 | 9 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Adam L. Perlman, Benjamin J. Behrendt, David J. Lehr, Arlene L. Chow, Michelle L. Ernst, Marc N. Zubick and Yi Sun - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| May 10, 2021 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford, Joseph E. Lasher and Paula S. Fritsch - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Jacobs, Karen) |
| May 7, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by KAI Pharmaceuticals, Inc., Amgen Inc.. Aurobindo Pharma USA Inc. served on 5/7/2021, answer due 5/28/2021. (Blumenfeld, Jack) |
| May 6, 2021 | 1 | Main Document (15) Docket Text: COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3610104.) - filed by KAI Pharmaceuticals, Inc., Amgen Inc. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(kmd) |
| May 6, 2021 | 1 | Exhibit A-B (60) |
| May 6, 2021 | 1 | Civil Cover Sheet (1) |
| May 6, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| May 6, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/26/2021. Date of Expiration of Patent: 6/27/2034.Thirty Month Stay Deadline: 8/7/2024. (kmd) |
| May 6, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,938 B2; 10,344,765 B2. (kmd) |
| May 6, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for KAI Pharmaceuticals, Inc. - filed by Amgen Inc., KAI Pharmaceuticals, Inc. (kmd) |
| May 6, 2021 | 6 | Summons Issued - Electronic (4) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| May 6, 2021 | 1 | Complaint* (1) |
